IL1B and endothelial dysfunction: Furthermore, TMAO contributes to atherosclerosis and endothelial dysfunction by promoting macrophage cholesterol accumulation and activating pro-inflammatory pathways such as NF-κB and MAPK, which lead to increased expression of adhesion molecules and cytokines (IL-1β, IL-18, TNF-α) [81,82,83,84,85].